Sage Therapeutic Stock Target Price and Analyst Consensus
| SAGE Stock | USD 9.11 0.03 0.33% |
The current analyst and expert consensus on Sage Therapeutic is Buy with 15 hold recommendations. The current projected Sage Therapeutic target price consensus is 8.21 with 19 analyst opinions. One of the most common ways Sage Therapeutic analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Sage Therapeutic vendors, executives, and/or customers. Sage Therapeutic recommendation module provides expert sentiment on the projected Sage Therapeutic target price to derive its highest and lowest estimates based on target price standard deviation of 4.9178.
Lowest Forecast 7.47 | Highest Forecast 9.12 | Target Price 8.21 |
It's important to approach Sage Therapeutic's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Sage Therapeutic Target Price Consensus
Sage target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Sage Therapeutic's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 19 | Buy |
Most Sage analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Sage stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Sage Therapeutic, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSage Therapeutic Target Price Projection
Sage Therapeutic's current and average target prices are 9.11 and 8.21, respectively. The current price of Sage Therapeutic is the price at which Sage Therapeutic is currently trading. On the other hand, Sage Therapeutic's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Sage Therapeutic Market Quote on 19th of July 2025
Target Price
Analyst Consensus On Sage Therapeutic Target Price
Sage Therapeutic Analyst Ratings
Sage Therapeutic's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Sage Therapeutic stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Sage Therapeutic's financials, market performance, and future outlook by experienced professionals. Sage Therapeutic's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Sage Therapeutic price targets
Sage Therapeutic's stock target price is an estimate of its future price, usually made by analysts. Using Sage Therapeutic's target price to determine if it is a suitable investment can be done through the following steps:- Look at Sage Therapeutic's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sage Therapeutic's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Sage Therapeutic Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sage Therapeutic is a key component of Sage Therapeutic valuation and have some predictive power on the future returns of a Sage Therapeutic.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 30 shares | |
 | Blockchain Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Cash Cows Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Banking Invested over 40 shares | |
 | ESG Investing Invested few shares | |
Check out Macroaxis Advice on Sage Therapeutic to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Please note, the presentation of Sage Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sage Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sage Therapeutic's management manipulating its earnings.